初始透析对尿素循环障碍的短期健康结果的严重度调整评估
Matthias Zielonka1, Stefan Kölker1, Sven F Garbade1
1Heidelberg University, Medical Faculty Heidelberg, and Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany.
Molecular genetics and metabolism
|September 19, 2024
概括
在尿素循环障碍 (UCD) 中的初始透析显示了多种生存益处. 虽然它没有改善男性甲酸转糖酶缺乏症 (mOTC-D) 的结果,但它可能有利于1型林血病 (CTLN1) 和阿尔金酸性酸性尿症 (ASA) 患者.
科学领域:
- 生物化学和遗传学 生物化学和遗传学
- 儿科脏病学 儿科脏病学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 尿素循环障碍 (UCD) 可以导致新生儿严重的高氨血性衰减补偿.
- 通过连续脏替代疗法进行体外解毒是标准的治疗方法.
- 目前用于启动透析的指示在全球范围内不一致,阻碍了结果评估.
研究的目的:
- 为了比较初始透析对UCD患者的生存和神经认知结果的治疗效果.
- 分析严重程度调整的透析和非透析患者队列中的结果.
主要方法:
- 对108名患有严重UCD表型的个体进行了回顾性比较分析.
- 基于基因型特定疾病预测模型的分层.
- 在男性鸟转糖酶缺乏症 (mOTC-D),1型素血病 (CTLN1) 和阿尔金酸性酸性尿症 (ASA) 中评估生存和神经认知参数.
主要成果:
- 死亡率与血氨水平的峰值相关,独立于mOTC-D的初始透析.
- 初始透析显示CTLN1的生存率有所改善,ASA的趋势有所改善.
- 在透析和非透析组之间,随后的代谢失补偿或神经认知结果没有显著差异.
结论:
- 初始透析与mOTC-D中改善的生存率或在UCD亚型中更好的神经认知结果无关.
- 透析可能为CTLN1和ASA患者提供生存益处.
- 需要进一步的研究来完善UCD的透析指示.
相关概念视频
Dialysis
276
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
276
Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Factors Affecting Renal Clearance: Renal Impairment
61
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
61
Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
143
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
143
Renal Drug Excretion: Tubular Reabsorption
133
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
133


